A Multi-Center Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Systemic Lupus Erythematosus

Brief description of study

The purpose of this biomarker testing is to study the effects of BMS-986165 and other medicines you are taking on the body and to learn more about Systemic Lupus Erythematosus, autoimmunity, and associated medical conditions under study. The work may involve all aspects or possible causes of these diseases and conditions, including but not limited to inflammation, autoimmunity, cardiovascular health, and metabolic syndrome pathways (fibrosis, obesity, diabetes mellitus, heart disease). These purposes are directly related to the clinical questions in the main study and will further the understanding of how BMS-986165 works in Systemic Lupus Erythematosus.

Clinical Study Identifier: s19-01545
ClinicalTrials.gov Identifier: NCT03920267
Principal Investigator: David H. Goddard.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.